Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Maria Mustachio

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Molecular Cancer Therapeutics|December 5, 2020
A Novel CDK2/9 Inhibitor CYC065 Causes Anaphase Catastrophe and Represses Proliferation, Tumorigenesis, and Metastasis in Aneuploid CancersMasanori Kawakami, Lisa Maria Mustachio, Yulong Chen, et al.
Journal of the National Cancer Institute|April 5, 2017
Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung CancerMasanori Kawakami, Lisa Maria Mustachio, Jaime Rodriguez-Canales, et al.
Molecular Cancer Research : MCR|March 1, 2017
Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung CancerLisa Maria Mustachio, Yun Lu, Laura J Tafe, et al.
Molecular Cancer Therapeutics|July 31, 2019
Tyrosine Threonine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and PolyploidyLin Zheng, Zibo Chen, Masanori Kawakami, et al.
Cancer Research|March 27, 2015
CDK2 Inhibition Causes Anaphase Catastrophe in Lung Cancer through the Centrosomal Protein CP110Shanhu Hu, Alexey V Danilov, Kristina Godek, et al.
ACS Medicinal Chemistry Letters|February 18, 2026
Structure-Guided Development of NRAS G12D Inhibitors Based on a 5‑Azaindole CoreJoshua B Cox, Vinay Nair, Pijus Mandal, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Molecular Cancer Therapeutics|December 5, 2020
A Novel CDK2/9 Inhibitor CYC065 Causes Anaphase Catastrophe and Represses Proliferation, Tumorigenesis, and Metastasis in Aneuploid CancersMasanori Kawakami, Lisa Maria Mustachio, Yulong Chen, et al.
Journal of the National Cancer Institute|April 5, 2017
Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung CancerMasanori Kawakami, Lisa Maria Mustachio, Jaime Rodriguez-Canales, et al.
Molecular Cancer Research : MCR|March 1, 2017
Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung CancerLisa Maria Mustachio, Yun Lu, Laura J Tafe, et al.
Molecular Cancer Therapeutics|July 31, 2019
Tyrosine Threonine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and PolyploidyLin Zheng, Zibo Chen, Masanori Kawakami, et al.
Cancer Research|March 27, 2015
CDK2 Inhibition Causes Anaphase Catastrophe in Lung Cancer through the Centrosomal Protein CP110Shanhu Hu, Alexey V Danilov, Kristina Godek, et al.
ACS Medicinal Chemistry Letters|February 18, 2026
Structure-Guided Development of NRAS G12D Inhibitors Based on a 5‑Azaindole CoreJoshua B Cox, Vinay Nair, Pijus Mandal, et al.
Pageof 3